News

Join Knight Therapeutics for Their Q3 Financial Results Review

Join Knight Therapeutics for Their Q3 Financial Results Review

Join Knight Therapeutics for Their Q3 Financial Results Review

Knight Therapeutics Inc. (TSX: GUD) a prominent specialty pharmaceutical company, is set to unveil its financial performance for the third quarter of 2024. The eagerly awaited results will be disclosed on the morning of a specified date, well ahead of market hours, allowing investors and stakeholders to assess the company's financial health directly.

Upcoming Conference Call Details

In light of the recent financial performance announcement, Knight Therapeutics encourages everyone interested in the company's trajectory to participate in a related conference call. This interactive session will provide a platform for insights into the company's advancements and growth plans.

Key Information on the Conference Call

Participants can mark their calendars for the following details:

  • Date: A specified date
  • Time: 8:30 a.m. ET
  • Telephone Connection: For listeners in North America, a toll-free line is available at 1-800-836-8184, while international participants can dial 1-289-819-1350.

Webcast Availability

In recognition of the technological advances in communication, Knight Therapeutics will also offer an audio webcast for those who wish to join virtually. This option provides a convenient and accessible way for everyone to stay informed.

About Knight Therapeutics Inc.

Headquartered in Montreal, Canada, Knight Therapeutics Inc. is a key player in the specialty pharmaceutical industry. The company aims to acquire, in-license, and market pharmaceutical products specifically tailored for Canadian and Latin American markets. Knight operates through several Latin American subsidiaries, including United Medical, Biotoscana Farma, and Laboratorio LKM, ensuring robust market penetration and effective distribution.

Current Operations and Growth Strategies

Knight Therapeutics continues to expand its portfolio and geographic reach. Their commitment to enhancing the healthcare landscape is evident as they introduce innovative solutions for unmet medical needs in the Latin America region. As the company prepares for its upcoming announcements, investors eagerly anticipate insights into how these efforts are translating into financial results.

Our Investor Relations Team

For any inquiries or further information regarding Knight Therapeutics, stakeholders are encouraged to reach out directly to their investor relations team:

  • Samira Sakhia, President & CEO - T: 514.484.4483
  • Arvind Utchanah, CFO - T: +598.2626.2344

Both Samira and Arvind are available to address any questions and provide further clarity on the company's operations and initiatives.

Frequently Asked Questions

What are Knight Therapeutics' core business focuses?

Knight Therapeutics specializes in acquiring and commercializing pharmaceutical products primarily for Canada and Latin America.

When will Knight Therapeutics release its Q3 financial results?

The release is scheduled for a specified date before market opening, allowing for timely analysis.

How can I participate in the conference call?

Interested parties can dial the provided toll-free number or join via the designated audio webcast to stay updated.

Who can I contact for investor-related inquiries?

Samira Sakhia, the CEO, and Arvind Utchanah, the CFO, can be contacted for any investor relations questions.

What subsidiaries does Knight have in Latin America?

The company operates through subsidiaries such as United Medical, Biotoscana Farma, and Laboratorio LKM, enhancing its market presence.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

2026 Rawlings Gold Glove Award Winners Announced

Updated Category News Views 65

Fielding Excellence on Display: The 2026 Rawlings Gold Glove Awards The Rawlings Gold Glove Awards have once again shone the spotlight on baseball's defensive maestros. Announced by Rawlings Sporting Goods Company, Inc., on November 1, 2026, this year's winners include 11 seasoned veterans and nine greenhorns who claimed their first-ever Gold Gloves. Unveiled during a...

Continue Reading
Knob-and-Tube Wiring: A Hidden Hazard Unveiled

Updated Category News Views 185

Unlocking the Mysteries of Knob-and-Tube Wiring Ever wondered if the wiring in your charming hundred-year-old home might be a ticking time bomb? Welcome to the world of knob-and-tube wiring. This blast from the past might just be hiding in those walls and could spell trouble. The History and Hazards of Knob-and-Tube This wiring system dates back to the 1880s, sticking...

Continue Reading
Double Down for Veterans Raises $20 Million Goal

Updated Category News Views 219

Helping Veterans: A Call That Never Fades If there's one thing that never changes, it's the enduring need to support those who have served. Semper Fi & America's Fund has been at the forefront of this mission for over a decade, and their annual Double Down for Veterans Match Campaign is nothing short of a testament to unwavering commitment. Kicking off for the 15th time,...

Continue Reading
Mastering Progressive Overload: Break Workout Plateaus

Updated Category News Views 149

Getting off the Fitness Merry-Go-Round You've been hitting the gym, feeling great, and suddenly—bam! You've hit a wall so hard you might as well be a bug on a windshield. That's where our buddy Joshua Bankes comes in, explaining the magic of progressive overload for fitness buffs. Understanding Plateau Phenomena Remember, results aren't linear. As you start a new...

Continue Reading
Decoding Real Estate Value: A Market Insider's Take

Updated Category News Views 328

Riding the Waves of Real Estate Pricing Homeowners dipping their toes into the real estate market know that setting the right price ain't a walk in the park. Luckily, Matt Nuzie, Shelton's real estate pro, has peeled back the layers on comparative market analyses (CMA) in a HelloNation piece. This isn't just about tossing a number out there—it's about understanding the...

Continue Reading
New Era Celebrates Valkyries' Groundbreaking WNBA Win

Updated Category News Views 157

A Surprising Win for a Rising Team In the world of sports, sometimes the odds are defied, and stories of triumph unfold that capture the imagination. The Golden State Valkyries did exactly that by snagging their first WNBA Championship title just a year after entering the league. It's a narrative right out of a Hollywood script—only this time, it's inked in real...

Continue Reading
Global Mayors Dialogue 2026: Ningbo Leads in Urban Ideas

Updated Category News Views 68

New Waves in City Collaboration Get this: from November 2 to 5, Ningbo, a key city nestled in east China's Zhejiang Province, is rolling out the red carpet for the 2026 Global Mayors Dialogue. Nearly 200 influential figures zooming into this seaside city isn't just for some aimless chit-chat. At the core, the theme is "Openness and Connectivity for Shared Opportunities."...

Continue Reading
China's Innovation Surge: Game Changer for Global Markets

Updated Category News Views 74

The Bold Shift in China's Economic Landscape Well, here's the scoop: China isn't just the world's assembly line anymore; it's gearing up to be a top-tier innovation hub. On the surface, might seem like another geopolitical spiel, but dig a little and you'll find it's a serious shake-up for global markets. We're talking about more than just products rolling out of...

Continue Reading
Chiropractic Insights: Differentiating Piriformis vs. Disc Pain

Updated Category News Views 196

Understanding Pain: Two Paths, One Problem Buttock and leg pain is a real drag, isn't it? We often brush it off as sciatica, but here's a twist: it might not be the usual corporate villain—a herniated disc. Instead, we could be dealing with an underdog called piriformis syndrome. According to Dr. Mitch Quill, D.C., of HelloNation fame, understanding these nuances isn't...

Continue Reading
iQIYI's AI Studio: Future of Filmmaking or Flash in Pan?

Updated Category News Views 8

Introducing the AI Revolution in Film Here we are, folks, standing at the intersection of film and artificial intelligence. China's entertainment behemoth, iQIYI, has just launched what they're touting as the country's first AI Film Studio over in Shanghai. Kicking things off, they've got "Cop in Trouble" queued up, a film that’s promising to leverage the unbridled...

Continue Reading

Top 5 Most Recently Viewed Articles

Benitec Biopharma Reports Operational Gains Amid Financial Update

Updated Category News Views 82

Benitec Biopharma's Recent Financial and Operational Developments It's an exciting period for Benitec Biopharma Inc. as they unveil substantial progress in their clinical endeavors, particularly regarding the BB-301 gene therapy. This innovative treatment aims at addressing the challenges posed by Oculopharyngeal Muscular Dystrophy (OPMD), a rare genetic condition. The...

Continue Reading
Idorsia's Progress on Negotiations for Aprocitentan Rights

Updated Category News Views 156

Idorsia's Recent Developments on Aprocitentan Negotiations Idorsia Ltd today announced important updates regarding its ongoing negotiations for the global rights to its drug, aprocitentan. This pivotal medication has the potential to significantly impact patient care and is currently the subject of exclusive negotiations with an unnamed party. Originally, the company had...

Continue Reading
Neuronetics Achieves Growth and Expands Treatment Options in 2024

Updated Category News Views 225

Growth Highlights for 2024 Neuronetics, Inc. (NASDAQ: STIM) is paving the way in mental health care, showcasing substantial financial results in both the fourth quarter and the full year of 2024. This vertically integrated medical technology company has made remarkable strides in making neurohealth therapies accessible to patients in need. Fourth Quarter 2024 Performance...

Continue Reading
Nano Dimension's Q2 2025 Financial Insights and Future Plans

Updated Category News Views 319

Nano Dimension's Financial Performance Overview Nano Dimension Ltd. (NASDAQ: NNDM), known for its digital manufacturing solutions, has recently shared its impressive financial results for the second quarter, closing on June 30, 2025. Despite the backdrop of industry challenges, the company's revenue reached $25.8 million, reflecting a remarkable increase of 72.4% compared...

Continue Reading
Bridging Art and Science Through Creative Collaborations

Updated Category News Views 288

Collaboration Between CALQ and Université du Québec à Rimouski The CALQ (Conseil des arts et des lettres du Québec) has partnered with Université du Québec à Rimouski (UQAR) to create an exceptional bridge between the worlds of art and science. This partnership aims to connect artists from disciplines such as film, public art, and classical music with scientists...

Continue Reading